Autolus Therapeutics (AUTL) Net Margin (2017 - 2025)
Autolus Therapeutics posted quarterly Net Margin of 371.9% for Q4 2025, up 9482120.0% year-on-year from N/an in Q4 2024, and little changed on a QoQ basis from 373.3% in Q3 2025.
Autolus Therapeutics (AUTL) has 7 years of Net Margin data on file, last reported at 371.9% in Q4 2025.
- For the quarter ending Q4 2025, Net Margin rose 9482120.0% year-over-year to 371.9%; the trailing twelve-month figure through Dec 2025 stood at 381.4% (up 179712.0% YoY), and the FY2025 full-year result was 381.4%, up 179906.0% from the prior year.
- Net Margin for Q4 2025 stood at 371.9%, roughly flat from 373.3% in the prior quarter.
- Across five years, Net Margin topped out at 569.89% in Q4 2021 and bottomed at 14402966.1% in Q3 2021.
- The 5-year median for Net Margin is 2201.26% (2021), against an average of 1119318.07%.
- The widest annual swing landed in 2021, when Net Margin plunged 1439444670 bps; it then soared 9482120 bps in 2025.
- A 5-year view of Net Margin shows it stood at 569.89% in 2021, then plunged by 4018 bps to 22326.51% in 2022, then soared by 49 bps to 11292.86% in 2023, then sank by 743 bps to 95193.1% in 2024, then surged by 100 bps to 371.9% in 2025.
- The last three Net Margin figures came in at 371.9% (Q4 2025), 373.3% (Q3 2025), and 229.02% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 34.53% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 20.17% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 17.65% |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | -371.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -371.90% |
| Sep 30, 2025 | -373.30% |
| Jun 30, 2025 | -229.02% |
| Mar 31, 2025 | -781.13% |
| Dec 31, 2024 | -95,193.10% |
| Mar 31, 2024 | -521.68% |
| Sep 30, 2023 | -11,292.86% |
| Mar 31, 2023 | -3,081.35% |
| Mar 31, 2022 | -22,326.51% |
| Dec 31, 2021 | 569.89% |
| Sep 30, 2021 | -14,402,966.10% |
| Jun 30, 2021 | -2,201.26% |
| Mar 31, 2021 | -12,366.54% |
| Dec 31, 2020 | -1,400.99% |
| Sep 30, 2020 | -8,519.41% |
| Jun 30, 2020 | -10,936.86% |
| Mar 31, 2020 | -8,838.17% |
| Dec 31, 2017 | -3,257.14% |